Acadia Pharmaceuticals (ACAD) Capital Expenditures (2012 - 2026)
Acadia Pharmaceuticals' Capital Expenditures came in at $5.09 million for Q2 2026, compared with $297,000 a year earlier and down 2.4% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Capital Expenditures (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Acadia Pharmaceuticals reported Capital Expenditures of $14.69 million; for FY2025, it was $4.69 million, up 796.7% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -9.2% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $523,000 in FY2024 (+946.0%), $50,000 in FY2023 and $1.12 million in FY2021 (-85.2%).
- The five-year range for quarterly Capital Expenditures is $1,000 (Q4 2021) to $5.21 million (Q1 2026).
- Business Quant data shows ACAD's Capital Expenditures at $5.21 million (Q1 2026), $4.01 million (Q4 2025) and $388,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Acadia Pharmaceuticals | 3.52 Bn | 44.08 Mn | 279.64 Mn | 5.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.09 Mn |
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 388,000.00 |
| Jun 30, 2025 | 297,000.00 |
| Dec 31, 2024 | 453,000.00 |
| Sep 30, 2024 | 70,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 45,000.00 |
| Mar 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 1.72 Mn |
| Jun 30, 2020 | 2.93 Mn |
| Mar 31, 2020 | 934,000.00 |
| Dec 31, 2019 | 207,000.00 |
| Sep 30, 2019 | 80,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 822,000.00 |
| Dec 31, 2018 | 526,000.00 |
| Sep 30, 2018 | 1.02 Mn |
API Access
Acadia Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();